e
26
20
2
4e
16
9
7
0
19
1
49
2
2
1d
3a
Back to Top
2c
d
2
1e
e
8
1b
1d
18
89
28
1d
2 29
1d
25
28
Zhenhao Shi
4fResearch Assistant Professor of Psychiatry
7
61
Department: Psychiatry
4
1
b
1d
46
Contact information
5f
4
3
3
3
2
4
b
1f
5f
3535 Market St Ste 500
Philadelphia, PA 19104
26
Philadelphia, PA 19104
35
f
13
Education:
21 7 BS 17 (Psychology) c
2a Peking University, 2009.
21 8 PhD 23 (Cognitive Neuroscience) c
2a Peking University, 2014.
c
3
3
21
21 7 BS 17 (Psychology) c
2a Peking University, 2009.
21 8 PhD 23 (Cognitive Neuroscience) c
2a Peking University, 2014.
c
1f
Post-Graduate Training
24 85 Postdoctoral Fellow in Health Communication, Annenberg Public Policy Center, University of Pennsylvania, 2014-2016.
24 b1 Postdoctoral Fellow in Addiction, Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, 2016-2021.
c
3
3
8d
Permanent link24 85 Postdoctoral Fellow in Health Communication, Annenberg Public Policy Center, University of Pennsylvania, 2014-2016.
24 b1 Postdoctoral Fellow in Addiction, Center for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, 2016-2021.
c
2 29
21
1e
1d
24
76
e 29
27
Description of Research Expertise
d1 Brain imaging, Public health, Social neuroscience, Translational neuroscience, Computational psychiatry, Substance use disorder, Tobacco control, Health communication, Cross-cultural psychologye 29
23
18b McKinstry, D.,* Shi, Z.,* Ramos-Rolón, A. P., Phillips, J., Das, S., Li, X., Hager, N. M., Pond, T., Volkow, N. D., Kranzler, H. R., Dubroff, J. G., Nasrallah, I. M., Wiers, C. E.: Hippocampal volume and brain tau pathology in opioid use disorder: associations with non-fatal opioid overdose. Addiction Neuroscience 2026.
186 Liu, J., Wang, Y., Fabbricatore, J. L., Norton, E., Markey, C. E., McMains, J. T., Worsdale, A., Ye, T., Shi, Z., & Sweet, L. H.: Neural predictors of vaping: covert emotional engagement versus reactance to overt emotional appeals in vaping prevention message processing. American Journal of Preventive Medicine 2026.
10a Brier, L. M., Langleben, D. D., Wiers, C. E., & Shi, Z.: Long-acting naltrexone restores network connectivity in subjects with comorbid cannabis and opioid use disorder. Addiction Biology 2026.
15f Ramos-Rolón, A. P., Langleben, D. D., Lynch, K. G., Wiers, C. E., & Shi, Z.: Emotional arousal of graphic cigarette warning labels loses its beneficial effects on craving reduction after repeated exposure – a longitudinal neuroimaging study. Drug and Alcohol Dependence 2026.
12c Hager NM, Wang X, Ramos-Rolón AP, Childress AR, Langleben DD, Wiers CE, Shi Z.: Brain network segregation is associated with drug use severity in individuals with opioid use disorder. Drug Alcohol Depend 276: 112863, Sep 2025.
fe Shi Z, Wang AL, Liu J, Audrain-McGovern J, Lynch KG, Loughead J, Langleben DD.: Delayed Effects of Cigarette Graphic Warning Labels on Smoking Behavior. Am J Health Promot Jul 2025.
13d Liu J, Shi Z, Fabbricatore JL, McMains JT, Worsdale A, Jones EC, Wang Y, Sweet LH.: Vaping and Smoking Cue Reactivity in Young Adult Nonsmoking Electronic Cigarette Users: A Functional Neuroimaging Study. Nicotine Tob Res 27: 762-766, Mar 2025.
122 Ramos-Rolón AP, Langleben DD, Lynch KG, Wiers CE, Shi Z.: Effects of emotional arousal on amygdala neural response and cigarette craving reduction during repeated exposure to graphic warning labels. medRxiv Mar 2025.
f2 Brier LM, Langleben DD, Wiers CE, Shi Z.: Long-acting naltrexone restores network connectivity in subjects with co-morbid cannabis and opioid use disorder. bioRxiv 2025.
2c
7
1d
1f
Selected Publications
1cb Li, X., Young, A. J., Shi, Z., Byanyima, J., Vesslee, S., Reddy, R., Pond, T., Elliott, M., Reddy, R. R., Doot, R. K., van der Veen, J. W., Kranzler, H. R., Nanga, R. P. R., Dubroff, J. G., & Wiers, C. E.: Pharmacokinetic effects of a single-dose nutritional ketone ester supplement on brain glucose and ketone metabolism in alcohol use disorder. Psychiatry Research: Neuroimaging 2026.18b McKinstry, D.,* Shi, Z.,* Ramos-Rolón, A. P., Phillips, J., Das, S., Li, X., Hager, N. M., Pond, T., Volkow, N. D., Kranzler, H. R., Dubroff, J. G., Nasrallah, I. M., Wiers, C. E.: Hippocampal volume and brain tau pathology in opioid use disorder: associations with non-fatal opioid overdose. Addiction Neuroscience 2026.
186 Liu, J., Wang, Y., Fabbricatore, J. L., Norton, E., Markey, C. E., McMains, J. T., Worsdale, A., Ye, T., Shi, Z., & Sweet, L. H.: Neural predictors of vaping: covert emotional engagement versus reactance to overt emotional appeals in vaping prevention message processing. American Journal of Preventive Medicine 2026.
10a Brier, L. M., Langleben, D. D., Wiers, C. E., & Shi, Z.: Long-acting naltrexone restores network connectivity in subjects with comorbid cannabis and opioid use disorder. Addiction Biology 2026.
15f Ramos-Rolón, A. P., Langleben, D. D., Lynch, K. G., Wiers, C. E., & Shi, Z.: Emotional arousal of graphic cigarette warning labels loses its beneficial effects on craving reduction after repeated exposure – a longitudinal neuroimaging study. Drug and Alcohol Dependence 2026.
12c Hager NM, Wang X, Ramos-Rolón AP, Childress AR, Langleben DD, Wiers CE, Shi Z.: Brain network segregation is associated with drug use severity in individuals with opioid use disorder. Drug Alcohol Depend 276: 112863, Sep 2025.
fe Shi Z, Wang AL, Liu J, Audrain-McGovern J, Lynch KG, Loughead J, Langleben DD.: Delayed Effects of Cigarette Graphic Warning Labels on Smoking Behavior. Am J Health Promot Jul 2025.
13d Liu J, Shi Z, Fabbricatore JL, McMains JT, Worsdale A, Jones EC, Wang Y, Sweet LH.: Vaping and Smoking Cue Reactivity in Young Adult Nonsmoking Electronic Cigarette Users: A Functional Neuroimaging Study. Nicotine Tob Res 27: 762-766, Mar 2025.
122 Ramos-Rolón AP, Langleben DD, Lynch KG, Wiers CE, Shi Z.: Effects of emotional arousal on amygdala neural response and cigarette craving reduction during repeated exposure to graphic warning labels. medRxiv Mar 2025.
f2 Brier LM, Langleben DD, Wiers CE, Shi Z.: Long-acting naltrexone restores network connectivity in subjects with co-morbid cannabis and opioid use disorder. bioRxiv 2025.
2c